DICLOPHENAC POTASSIUM VERSUS CEPHTAZIDIME FOR REDUCTION OF POST ERCP PANCREATITIS IN AVERAGE RISK PATIENTS-RANDOMISED DOUBLE BLIND CONTROLLED TRIAL

Goran Hauser  1     Ivana Blazevic  2     Nermin Salkic  3     Goran Poropat  4     Vanja Giljaca     Zlatko Bulic     Davor Stimac    
1 Department of Internal Med., Division of Gastroent,CLINICAL HOSPITAL CENTRE, RIJEKA, CROATIA,Rijeka,Croatia
2 Department of Emergency Medicine,CLINICAL HOSPITAL CENTRE, RIJEKA, CROATIA,Rijeka,Croatia
3 Department of Gastroenterology and Hepatology,University Clinical Centre Tuzla,Tuzla,Bosnia and Herzegovina
4 Department of Internal Med.,

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing